Abstract
Objectives: Little is known about the mental health outcomes of hospitalized COVID-19 patients. The aims of the study were: (1) to examine the trajectories of anxiety, depression, and pandemic-related stress factors (PRSF) of COVID-19 hospitalized patients one-month following hospitalization; (2) to assess the presence of post-traumatic stress symptoms (PTSS) a month after hospitalization; (3) to identify baseline risk and protective factors that would predict PTSS one month after hospitalization. Methods: We contacted hospitalized COVID-19 patients (n = 64) by phone, at three time-points: during the first days after admission to the hospital (T1); after ~two weeks from the beginning of hospitalization (T2), and one month after hospitalization (T3). At all time-points we assessed the levels of anxiety and depression symptoms, as well as PRSF. At T3, PTSS were assessed. Results: The levels of depressive and anxiety symptoms decreased one-month following hospitalization. Moreover, higher levels of anxiety (standardized β = 1.15, 95% CI = 0.81–1.49, p < 0.001) and depression (β = 0.97, 95% CI = 0.63–1.31 p < 0.001) symptoms during the first week of hospitalization, feeling socially disconnected (β = 0.59, 95% CI = 0.37–0.81 p < 0.001) and experiencing a longer hospitalization period (β = 0.25, 95% CI = 0.03–0.47 p = 0.026) predicted higher PTSS scores a month post-hospitalization. Conclusions: We identified early hospitalization risk factors for the development of PTSS one month after hospitalization that should be targeted to reduce the risk for PTSS.
Original language | English |
---|---|
Article number | 110399 |
Journal | Journal of Psychosomatic Research |
Volume | 143 |
DOIs | |
State | Published - Apr 2021 |
Bibliographical note
Publisher Copyright:© 2021 Elsevier Inc.
Funding
This work was supported by grants from Foundation Dora, Geneva, Switzerland and the Binational Science Foundation (Grant No. 2017369 ) and by Kirsh Foundation, New York, United States . The funding source had no role in the study design, collection, analysis, or interpretation of data, the writing of the article, or decision to submit the article for publication. We wish to thank Shira Bursztyn and Noy Meir for their assistance in interviewing the participants. This work was supported by grants from Foundation Dora, Geneva, Switzerland and the Binational Science Foundation (Grant No. 2017369) and by Kirsh Foundation, New York, United States. The funding source had no role in the study design, collection, analysis, or interpretation of data, the writing of the article, or decision to submit the article for publication.
Funders | Funder number |
---|---|
Foundation Dora, Geneva | |
Kirsh Foundation | |
Shira Bursztyn | |
United States-Israel Binational Science Foundation | 2017369 |
Keywords
- Anxiety
- COVID-19
- Depression
- Mental health
- PTSS
- Patients